PCSA: Processa Pharmaceuticals, Inc. Stock

by  •  • Comments Off on PCSA: Processa Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1.34
Enterprise Value ($M) 0.15
Book Value ($M) 1.70
Book Value / Share 0.32
Price / Book 0.79
NCAV ($M) 0.34
NCAV / Share 0.06
Price / NCAV 3.93

Profitability (mra)
Return on Invested Capital (ROIC) -6.70
Return on Assets (ROA) -1.19
Return on Equity (ROE) -1.33

Liquidity (mrq)
Quick Ratio 1.22
Current Ratio 1.22

Balance Sheet (mrq) ($M)
Current Assets 1.87
Assets 3.23
Liabilities 1.53
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -12.05
Net Income -11.85
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Warrants n/a
Earnings Per Share Common Shares Issued And Outstanding Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Common Shares Issued And Outstanding Basic n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -11.25
Cash from Investing -0.00
Cash from Financing 7.73

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-10-30 10-Q United States Securities and Exchange Commission Washington, D.C. 20549 FORM 10-Q
2024-08-13 10-Q United States Securities and Exchange Commission Washington, D.C. 20549 FORM 10-Q
2024-05-10 10-Q United States Securities and Exchange Commission Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 276,449 1,199,735 23.04
2025-04-16 248,602 1,343,511 18.50
2025-04-15 1,010,971 4,974,598 20.32

(click for more detail)

Similar Companies
OTLK – Outlook Therapeutics, Inc. PALI – Palisade Bio, Inc.
PASG – Passage Bio, Inc. PDSB – PDS Biotechnology Corporation
PHIO – Phio Pharmaceuticals Corp.


Financial data and stock pages provided by
Fintel.io